Formamide

Formamide

SCHEMBL27614973

CCc1nccnc1CC.NC=O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
NOS3 P29474 3/20 0.34
NOS2 P35228 3/20 0.34
NOS1 P29475 2/20 0.34
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRB2 P47870 1/20 0.31
GABRA4 P48169 1/20 0.31
GABRE P78334 1/20 0.31
GABRA6 Q16445 1/20 0.31
GABRG1 Q8N1C3 1/20 0.31
GABRG3 Q99928 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34472956 0.84 PDE3B (0.39) PDE3BPDE3ANOS3NOS2NOS1
SCHEMBL1131513 0.84 PDE3B (0.39) PDE3BPDE3ANOS3NOS2NOS1
SCHEMBL6449401 0.83 PDE3B (0.35) PDE3BPDE3A
Ammonia Solution, Strong SCHEMBL28980458 0.81 PDE3B (0.38) PDE3BPDE3ANOS3NOS2NOS1
Formamide SCHEMBL10696206 0.79 ALDH1A1 (0.35) PDE3BPDE3AGABRA1GABRB2
SCHEMBL7497070 0.77 PDE3B (0.33) PDE3BPDE3ANOS3NOS2NOS1
SCHEMBL3931270 0.76 PDE3B (0.34) PDE3BPDE3A
SCHEMBL29954185 0.76 PDE3B (0.34) PDE3BPDE3A
Formamide SCHEMBL29265662 0.76 PDE3B (0.36) PDE3BPDE3ANOS3NOS2NOS1
Formamide SCHEMBL27824881 0.75 NOS3 (0.37) PDE3BPDE3ANOS3NOS2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1726042-A Benzo[d]azepine derivatives for the treatment of neurological disorders GLAXO GROUP LTD (GB) 2006-01-25 CN disclosed